Busse Convenience Kits With Swab Products Recalled for Manufacturing Validation Issues
Busse Convenience kits containing swab/swabstick drug products manufactured by Professional Disposables International are recalled due to uncertainty about manufacturing test method validation.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Per the rubric, risk-of-harm products without reported injury score as High (3). Manufacturing validation uncertainty on drug/medical swab products represents a risk-of-harm situation with no illnesses or injuries reported in the source.
Plain-English summary
Busse Convenience kits containing one or more swab/swabstick drug products manufactured by Professional Disposables International (PDI) have been recalled.
The recall was issued due to uncertainty regarding the adequacy of validation of the test methods used during manufacturing of these drug products.
The recalled kits were distributed nationwide. The affected lot numbers are 2031076 and 2130823 with UDI 00849233017306. Approximately 99 units were recalled.
The recalled product
- Product
- 4.5 MM Pellet Insertion Tray Catalog Number: B8121R1
- Manufacturer
- Busse Hospital Disposables, Inc.
- Category
- Drug
- Hazard
- manufacturing-validation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Numbers: 2031076 2130823 UDI:00849233017306
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27